Novavax’s COVID-19 booster authorized in Canada
Shares of Novavax Inc. NVAX, -3.17% were up 2.4% in premarket trading on Friday after…
Read MoreShares of Novavax Inc. NVAX, -3.17% were up 2.4% in premarket trading on Friday after…
Read MoreThe Food and Drug Administration authorized Novavax Inc.’s NVAX, -2.58% COVID-19 vaccine for use in…
Read MoreNovavax’s NVAX, +1.04% COVID-19 vaccine candidate played a front-and-center role during this week’s debate about…
Read More